Clinical Trial Update: Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors [Phase 1]

View source ↗

Summary

Clinical trial update for RMC-5127 in KRAS G12V-mutant advanced solid tumors shows Phase 1 recruitment ongoing across non-small cell lung cancer, colorectal can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• RMC-5127

Snippet

Sponsor: Revolution Medicines, Inc. | Conditions: Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) | Phase 1 | Status: RECRUITING